Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PENK,Proenkephalin-A,Inverse variance weighted,21,0.96 [0.83-1.10],0.541416636995911
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.98 [0.79-1.22],0.84386729420404
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.94 [0.75-1.20],0.631089960188531
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NUCB2,Nucleobindin-2,Inverse variance weighted,28,1.05 [0.93-1.20],0.416197411122341
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.20 [0.91-1.57],0.194407807248916
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,1.08 [0.98-1.19],0.111099303291238
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.77 [0.25-2.36],0.65240452877964
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASE6,Ribonuclease K6,Inverse variance weighted,20,0.90 [0.81-1.00],0.0525237487232445
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.08 [0.90-1.28],0.411611620178
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.96 [0.49-1.86],0.898952305805756
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,0.95 [0.84-1.09],0.468815162322302
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.98 [0.66-1.46],0.911757556250925
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TFF3,Trefoil factor 3,Inverse variance weighted,10,1.35 [1.05-1.72],0.0174989885413896
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,0.97 [0.79-1.19],0.768555439585701
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.31 [0.84-2.07],0.235640123553479
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.98 [0.88-1.09],0.693147267499093
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,0.89 [0.59-1.34],0.567773118889141
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.05 [0.89-1.24],0.545079662090792
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.93 [0.66-1.31],0.69392298944867
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.07 [0.91-1.26],0.427735467937116
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.02 [0.92-1.13],0.659002268934233
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.04 [0.95-1.15],0.383759610975536
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.34 [0.83-2.14],0.227954090747119
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EFNA1,Ephrin-A1,Inverse variance weighted,15,1.11 [0.97-1.27],0.116311966416806
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PGF,Placenta growth factor,Inverse variance weighted,8,0.92 [0.56-1.51],0.742698284993171
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ULBP2,UL16-binding protein 2,Inverse variance weighted,37,1.05 [0.98-1.12],0.157363052030589
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.78 [0.50-1.23],0.288541976451328
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LAYN,Layilin,Inverse variance weighted,23,0.89 [0.77-1.03],0.105941294378185
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.06 [0.80-1.41],0.701420638187162
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.31 [0.86-1.98],0.20870932238034
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.88 [0.80-0.97],0.0078171269738108
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.00 [0.85-1.18],0.963139355469617
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.91 [0.83-1.00],0.0630083029706694
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.10 [0.99-1.22],0.0716541820415414
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",AGRN,Agrin,Inverse variance weighted,31,1.02 [0.90-1.16],0.733492604097375
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.96 [0.74-1.24],0.730918366353086
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.85 [0.65-1.13],0.268962876723127
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.07 [0.90-1.26],0.452148847537848
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.92 [0.63-1.36],0.686783417540437
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PSAP,Prosaposin,Inverse variance weighted,13,0.91 [0.78-1.07],0.26013361177666
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NECTIN2,Nectin-2,Inverse variance weighted,8,0.95 [0.83-1.10],0.518086782592892
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,0.98 [0.90-1.07],0.660735425846995
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.21 [0.81-1.81],0.34097512812809
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,0.96 [0.83-1.10],0.565897203051763
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SHISA5,Protein shisa-5,Inverse variance weighted,16,0.73 [0.55-0.98],0.0343021643344524
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CD27,CD27 antigen,Inverse variance weighted,18,0.91 [0.79-1.04],0.162065454517721
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.07 [0.65-1.74],0.797428265563979
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,1.01 [0.87-1.17],0.877492721414183
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.01 [0.83-1.21],0.955981676323413
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.87 [0.66-1.14],0.313088768803328
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",OCLN,Occludin,Inverse variance weighted,3,0.75 [0.53-1.07],0.115209330151189
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",NECTIN4,Nectin-4,Inverse variance weighted,12,0.95 [0.83-1.10],0.506352079716988
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,0.90 [0.52-1.55],0.698161121096514
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.90 [0.79-1.03],0.119384665016956
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,0.95 [0.87-1.03],0.182461075825564
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",DLL1,Delta-like protein 1,Inverse variance weighted,13,0.81 [0.66-0.99],0.0403413473849282
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.98 [0.64-1.49],0.91423253739881
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LGALS4,Galectin-4,Inverse variance weighted,19,1.03 [0.92-1.15],0.658584444532972
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CTSV,Cathepsin L2,Inverse variance weighted,34,0.93 [0.82-1.07],0.313966834564868
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.02 [0.81-1.28],0.88176980587824
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",COLEC12,Collectin-12,Inverse variance weighted,13,1.12 [0.89-1.40],0.339132377839147
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CTSL,Cathepsin L1,Inverse variance weighted,29,1.06 [0.91-1.24],0.459989045466885
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.14 [1.00-1.31],0.051138932475516
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.92 [0.73-1.16],0.469980979876025
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TSHB,Thyrotropin subunit beta,Inverse variance weighted,31,0.54 [0.43-0.68],2.58104213521741e-07
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.84 [0.70-1.02],0.0791710259304517
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.05 [0.95-1.17],0.320524717359658
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.26 [0.84-1.88],0.271011543022249
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SEMA3F,Semaphorin-3F,Inverse variance weighted,46,0.96 [0.84-1.11],0.605343974583176
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EPO,Erythropoietin,Inverse variance weighted,14,1.01 [0.85-1.21],0.895941995394623
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.81 [0.44-1.49],0.504144835054578
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CD302,CD302 antigen,Inverse variance weighted,17,0.92 [0.80-1.07],0.274740765803478
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.91 [0.73-1.14],0.42973263875644
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.09 [0.80-1.48],0.601185364387522
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.99 [0.54-1.81],0.968111874789088
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LMNB2,Lamin-B2,Inverse variance weighted,9,1.31 [0.93-1.85],0.125618756768084
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.55 [0.27-1.11],0.0952855452941052
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.90 [0.84-0.96],0.0006517419909141
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.07 [0.94-1.22],0.294792463899139
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.98 [0.80-1.20],0.840259694272693
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",DSC2,Desmocollin-2,Inverse variance weighted,16,0.83 [0.72-0.96],0.0116155780794267
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,0.98 [0.89-1.08],0.720065395906223
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.15 [0.71-1.85],0.570145430604868
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CD7,T-cell antigen CD7,Inverse variance weighted,12,1.00 [0.89-1.12],0.981440415644204
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.10 [0.98-1.23],0.11342538277955
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.02 [0.95-1.08],0.633983232463481
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",BSG,Basigin,Inverse variance weighted,8,1.16 [0.88-1.52],0.286008409483248
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",LGALS9,Galectin-9,Inverse variance weighted,39,1.03 [0.94-1.14],0.504122199924083
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CFD,Complement factor D,Inverse variance weighted,12,0.97 [0.82-1.15],0.734967560291108
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EFNA4,Ephrin-A4,Inverse variance weighted,5,1.07 [0.75-1.54],0.699411754885668
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.96 [0.81-1.14],0.632642109893797
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.97 [0.80-1.19],0.773564315353794
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.04 [0.68-1.61],0.841315738655142
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",AMBP,Protein AMBP,Inverse variance weighted,5,0.98 [0.73-1.30],0.867677499084752
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.01 [0.89-1.15],0.871365623610312
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.92 [0.46-1.84],0.824204887965287
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,35,1.04 [0.95-1.14],0.404032203664141
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.00 [0.90-1.11],0.961652818509604
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.06 [0.89-1.27],0.521612760425755
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.62 [0.34-1.13],0.118599058493191
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.27 [1.01-1.59],0.0431737812634206
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.99 [0.77-1.28],0.962336821110477
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",FAM3C,Protein FAM3C,Inverse variance weighted,5,1.43 [0.92-2.21],0.113458365392736
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.99 [0.64-1.52],0.949961793243727
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.85 [0.68-1.07],0.157101782345356
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.98 [0.72-1.35],0.916114762538819
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.12 [0.95-1.33],0.183369567245886
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",CST3,Cystatin-C,Inverse variance weighted,13,1.02 [0.89-1.18],0.768483874147894
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.69 [0.30-1.60],0.384443846651827
"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.66 [0.31-1.40],0.280104821134065
